KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mks (MKSI) Asset Writedowns and Impairment (2016 - 2025)

Mks' Asset Writedowns and Impairment history spans 17 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 119.51% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $45.0 million, changed N/A, while the annual FY2025 figure was $45.0 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $8.0 million at Mks, down from $10.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.8 billion in Q2 2023 and bottomed at -$41.0 million in Q4 2024.
  • The 5-year median for Asset Writedowns and Impairment is $10.0 million (2023), against an average of $106.7 million.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 45775.0% in 2023 before it crashed 510.0% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$14.0 million in 2021, then soared by 250.0% to $21.0 million in 2022, then plummeted by 52.38% to $10.0 million in 2023, then plummeted by 510.0% to -$41.0 million in 2024, then soared by 119.51% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for MKSI's Asset Writedowns and Impairment are $8.0 million (Q4 2025), $10.0 million (Q3 2025), and $10.0 million (Q2 2025).